Industry: Pharma & Healthcare
Published Date: 2024-04-17
Pages: 179 Pages
Report ld: 2695727
Request Sample
Customized Report
Metronidazole Market Size(US$)

CAGR 2024-2030
-0.5%
Market Size,2030
USD 109.1
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
The global Metronidazole market size was US$ 113 million in 2023 and is forecast to a readjusted size of US$ 109.1 million by 2030 with a CAGR of -0.5% during the forecast period 2024-2030.
Global Metronidazole key players include CordenPharma Farchemia, Tongji Pharmaceutical, Aarti Drugs, Manav Drugs, etc.
China is the largest market, with a share about 90%, followed by India, and Europe, both have a share over 10 percent.
In terms of product, Glyoxal Process is the largest segment, with a share over 85%. And in terms of application, the largest application is Metronidazole Tablets, followed by Metronidazole Capsule, Metronidazole Injection, etc.
In terms of sales (consumption) side, this report focuses on the sales of Metronidazole by regions (Countries), company, by type and by type. from 2019 to 2024 and forecast to 2030.
The global Metronidazole market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Metronidazole market. These figures have been provided in terms of both revenue and sales for the period 2019-2030. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Metronidazole in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Metronidazole manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7: Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8: China by company, by type and by application, sales, and revenue for each segment.
Chapter 9: APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Metronidazole sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Metronidazole Definition
1.2 Market by Type
1.2.1 Global Metronidazole Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Glyoxal Process
1.2.3 Ethidene Diamine Process
1.2.4 Others
1.3 Market Segment by Application
1.3.1 Global Metronidazole Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Metronidazole Tablets
1.3.3 Metronidazole Capsule
1.3.4 Metronidazole Injection
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Metronidazole Sales
2.1 Global Metronidazole Revenue Estimates and Forecasts 2019-2030
2.2 Global Metronidazole Revenue by Region: 2019 VS 2023 VS 2030
2.3 Global Metronidazole Revenue by Region
2.3.1 Global Metronidazole Revenue by Region (2019-2024)
2.3.2 Global Metronidazole Revenue by Region (2025-2030)
2.4 Global Metronidazole Sales Quantity Estimates and Forecasts 2019-2030
2.5 Global Metronidazole Sales Quantity by Region: 2019 VS 2023 VS 2030
2.6 Global Metronidazole Sales Quantity by Region
2.6.1 Global Metronidazole Sales Quantity by Region (2019-2024)
2.6.2 Global Metronidazole Sales Quantity by Region (2025-2030)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Metronidazole Sales Quantity by Manufacturers
3.1.1 Global Metronidazole Sales Quantity by Manufacturers (2019-2024)
3.1.2 Global Metronidazole Sales Quantity Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Companies by Metronidazole Sales in 2023
3.2 Global Metronidazole Revenue by Manufacturers
3.2.1 Global Metronidazole Revenue by Manufacturers (2019-2024)
3.2.2 Global Metronidazole Revenue Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Metronidazole Revenue in 2023
3.3 Global Metronidazole Sales Price by Manufacturers
3.4 Global Key Players of Metronidazole, Industry Ranking, 2022 VS 2023
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Metronidazole Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Metronidazole, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Metronidazole, Product Offered and Application
3.8 Global Key Manufacturers of Metronidazole, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Metronidazole Sales Quantity by Type
4.1.1 Global Metronidazole Historical Sales Quantity by Type (2019-2024)
4.1.2 Global Metronidazole Forecasted Sales Quantity by Type (2025-2030)
4.1.3 Global Metronidazole Sales Quantity Market Share by Type (2019-2030)
4.2 Global Metronidazole Revenue by Type
4.2.1 Global Metronidazole Historical Revenue by Type (2019-2024)
4.2.2 Global Metronidazole Forecasted Revenue by Type (2025-2030)
4.2.3 Global Metronidazole Revenue Market Share by Type (2019-2030)
4.3 Global Metronidazole Price by Type
4.3.1 Global Metronidazole Price by Type (2019-2024)
4.3.2 Global Metronidazole Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Metronidazole Sales Quantity by Application
5.1.1 Global Metronidazole Historical Sales Quantity by Application (2019-2024)
5.1.2 Global Metronidazole Forecasted Sales Quantity by Application (2025-2030)
5.1.3 Global Metronidazole Sales Quantity Market Share by Application (2019-2030)
5.2 Global Metronidazole Revenue by Application
5.2.1 Global Metronidazole Historical Revenue by Application (2019-2024)
5.2.2 Global Metronidazole Forecasted Revenue by Application (2025-2030)
5.2.3 Global Metronidazole Revenue Market Share by Application (2019-2030)
5.3 Global Metronidazole Price by Application
5.3.1 Global Metronidazole Price by Application (2019-2024)
5.3.2 Global Metronidazole Price Forecast by Application (2025-2030)
6 North America
6.1 North America Metronidazole Sales by Company
6.1.1 North America Metronidazole Revenue by Company (2019-2024)
6.1.2 North America Metronidazole Sales Quantity by Company (2019-2024)
6.2 North America Metronidazole Market Size by Type
6.2.1 North America Metronidazole Sales Quantity by Type (2019-2030)
6.2.2 North America Metronidazole Revenue by Type (2019-2030)
6.3 North America Metronidazole Market Size by Application
6.3.1 North America Metronidazole Sales Quantity by Application (2019-2030)
6.3.2 North America Metronidazole Revenue by Application (2019-2030)
6.4 North America Metronidazole Market Size by Country
6.4.1 North America Metronidazole Revenue by Country: 2019 VS 2023 VS 2030
6.4.2 North America Metronidazole Revenue by Country (2019-2030)
6.4.3 North America Metronidazole Sales Quantity by Country (2019-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Metronidazole Sales by Company
7.1.1 Europe Metronidazole Sales Quantity by Company (2019-2024)
7.1.2 Europe Metronidazole Revenue by Company (2019-2024)
7.2 Europe Metronidazole Market Size by Type
7.2.1 Europe Metronidazole Sales Quantity by Type (2019-2030)
7.2.2 Europe Metronidazole Revenue by Type (2019-2030)
7.3 Europe Metronidazole Market Size by Application
7.3.1 Europe Metronidazole Sales Quantity by Application (2019-2030)
7.3.2 Europe Metronidazole Revenue by Application (2019-2030)
7.4 Europe Metronidazole Market Size by Country
7.4.1 Europe Metronidazole Revenue by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Metronidazole Revenue by Country (2019-2030)
7.4.3 Europe Metronidazole Sales Quantity by Country (2019-2030)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Metronidazole Sales by Company
8.1.1 China Metronidazole Sales Quantity by Company (2019-2024)
8.1.2 China Metronidazole Revenue by Company (2019-2024)
8.2 China Metronidazole Market Size by Type
8.2.1 China Metronidazole Sales Quantity by Type (2019-2030)
8.2.2 China Metronidazole Revenue by Type (2019-2030)
8.3 China Metronidazole Market Size by Application
8.3.1 China Metronidazole Sales Quantity by Application (2019-2030)
8.3.2 China Metronidazole Revenue by Application (2019-2030)
9 APAC (excluding China)
9.1 APAC Metronidazole Sales by Company
9.1.1 APAC Metronidazole Sales Quantity by Company (2019-2024)
9.1.2 APAC Metronidazole Revenue by Company (2019-2024)
9.2 APAC Metronidazole Market Size by Type
9.2.1 APAC Metronidazole Sales Quantity by Type (2019-2030)
9.2.2 APAC Metronidazole Revenue by Type (2019-2030)
9.3 APAC Metronidazole Market Size by Application
9.3.1 APAC Metronidazole Sales Quantity by Application (2019-2030)
9.3.2 APAC Metronidazole Revenue by Application (2019-2030)
9.4 APAC Metronidazole Market Size by Region
9.4.1 APAC Metronidazole Revenue by Region: 2019 VS 2023 VS 2030
9.4.2 APAC Metronidazole Revenue by Region (2019-2030)
9.4.3 APAC Metronidazole Sales Quantity by Region (2019-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Metronidazole Sales by Company
10.1.1 Middle East, Africa and Latin America Metronidazole Sales Quantity by Company (2019-2024)
10.1.2 Middle East, Africa and Latin America Metronidazole Revenue by Company (2019-2024)
10.2 Middle East, Africa and Latin America Metronidazole Market Size by Type
10.2.1 Middle East, Africa and Latin America Metronidazole Sales Quantity by Type (2019-2030)
10.2.2 Middle East, Africa and Latin America Metronidazole Revenue by Type (2019-2030)
10.3 Middle East, Africa and Latin America Metronidazole Market Size by Application
10.3.1 Middle East, Africa and Latin America Metronidazole Sales Quantity by Application (2019-2030)
10.3.2 Middle East, Africa and Latin America Metronidazole Revenue by Application (2019-2030)
10.4 Middle East, Africa and Latin America Metronidazole Market Size by Country
10.4.1 Middle East, Africa and Latin America Metronidazole Revenue by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa and Latin America Metronidazole Revenue by Country (2019-2030)
10.4.3 Middle East, Africa and Latin America Metronidazole Sales Quantity by Country (2019-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Hongyuan Pharmaceutical
11.1.1 Hongyuan Pharmaceutical Company Information
11.1.2 Hongyuan Pharmaceutical Overview
11.1.3 Hongyuan Pharmaceutical Metronidazole Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.1.4 Hongyuan Pharmaceutical Metronidazole Products and Services
11.1.5 Hongyuan Pharmaceutical Metronidazole SWOT Analysis
11.1.6 Hongyuan Pharmaceutical Recent Developments
11.2 Yinhe Aarti Pharmaceutical
11.2.1 Yinhe Aarti Pharmaceutical Company Information
11.2.2 Yinhe Aarti Pharmaceutical Overview
11.2.3 Yinhe Aarti Pharmaceutical Metronidazole Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.2.4 Yinhe Aarti Pharmaceutical Metronidazole Products and Services
11.2.5 Yinhe Aarti Pharmaceutical Metronidazole SWOT Analysis
11.2.6 Yinhe Aarti Pharmaceutical Recent Developments
11.3 Saikang Pharmaceutical
11.3.1 Saikang Pharmaceutical Company Information
11.3.2 Saikang Pharmaceutical Overview
11.3.3 Saikang Pharmaceutical Metronidazole Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.3.4 Saikang Pharmaceutical Metronidazole Products and Services
11.3.5 Saikang Pharmaceutical Metronidazole SWOT Analysis
11.3.6 Saikang Pharmaceutical Recent Developments
11.4 Zhongan Pharmaceutical
11.4.1 Zhongan Pharmaceutical Company Information
11.4.2 Zhongan Pharmaceutical Overview
11.4.3 Zhongan Pharmaceutical Metronidazole Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.4.4 Zhongan Pharmaceutical Metronidazole Products and Services
11.4.5 Zhongan Pharmaceutical Metronidazole SWOT Analysis
11.4.6 Zhongan Pharmaceutical Recent Developments
11.5 Wuyao Pharmaceutical
11.5.1 Wuyao Pharmaceutical Company Information
11.5.2 Wuyao Pharmaceutical Overview
11.5.3 Wuyao Pharmaceutical Metronidazole Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.5.4 Wuyao Pharmaceutical Metronidazole Products and Services
11.5.5 Wuyao Pharmaceutical Metronidazole SWOT Analysis
11.5.6 Wuyao Pharmaceutical Recent Developments
11.6 Yichang Changjiang Pharmaceutical
11.6.1 Yichang Changjiang Pharmaceutical Company Information
11.6.2 Yichang Changjiang Pharmaceutical Overview
11.6.3 Yichang Changjiang Pharmaceutical Metronidazole Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.6.4 Yichang Changjiang Pharmaceutical Metronidazole Products and Services
11.6.5 Yichang Changjiang Pharmaceutical Metronidazole SWOT Analysis
11.6.6 Yichang Changjiang Pharmaceutical Recent Developments
11.7 Tongji Pharmaceutical
11.7.1 Tongji Pharmaceutical Company Information
11.7.2 Tongji Pharmaceutical Overview
11.7.3 Tongji Pharmaceutical Metronidazole Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.7.4 Tongji Pharmaceutical Metronidazole Products and Services
11.7.5 Tongji Pharmaceutical Metronidazole SWOT Analysis
11.7.6 Tongji Pharmaceutical Recent Developments
11.8 Hongda Pharmaceutical
11.8.1 Hongda Pharmaceutical Company Information
11.8.2 Hongda Pharmaceutical Overview
11.8.3 Hongda Pharmaceutical Metronidazole Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.8.4 Hongda Pharmaceutical Metronidazole Products and Services
11.8.5 Hongda Pharmaceutical Metronidazole SWOT Analysis
11.8.6 Hongda Pharmaceutical Recent Developments
11.9 Topsun Pharmaceutical
11.9.1 Topsun Pharmaceutical Company Information
11.9.2 Topsun Pharmaceutical Overview
11.9.3 Topsun Pharmaceutical Metronidazole Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.9.4 Topsun Pharmaceutical Metronidazole Products and Services
11.9.5 Topsun Pharmaceutical Metronidazole SWOT Analysis
11.9.6 Topsun Pharmaceutical Recent Developments
11.10 Unichem Laboratories
11.10.1 Unichem Laboratories Company Information
11.10.2 Unichem Laboratories Overview
11.10.3 Unichem Laboratories Metronidazole Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.10.4 Unichem Laboratories Metronidazole Products and Services
11.10.5 Unichem Laboratories Metronidazole SWOT Analysis
11.10.6 Unichem Laboratories Recent Developments
11.11 CordenPharma Farchemia
11.11.1 CordenPharma Farchemia Company Information
11.11.2 CordenPharma Farchemia Overview
11.11.3 CordenPharma Farchemia Metronidazole Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.11.4 CordenPharma Farchemia Metronidazole Products and Services
11.11.5 CordenPharma Farchemia Recent Developments
11.12 API Polpharma
11.12.1 API Polpharma Company Information
11.12.2 API Polpharma Overview
11.12.3 API Polpharma Metronidazole Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.12.4 API Polpharma Metronidazole Products and Services
11.12.5 API Polpharma Recent Developments
11.13 Manav Drugs
11.13.1 Manav Drugs Company Information
11.13.2 Manav Drugs Overview
11.13.3 Manav Drugs Metronidazole Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.13.4 Manav Drugs Metronidazole Products and Services
11.13.5 Manav Drugs Recent Developments
11.14 Aarey Drugs & Pharmaceuticals
11.14.1 Aarey Drugs & Pharmaceuticals Company Information
11.14.2 Aarey Drugs & Pharmaceuticals Overview
11.14.3 Aarey Drugs & Pharmaceuticals Metronidazole Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.14.4 Aarey Drugs & Pharmaceuticals Metronidazole Products and Services
11.14.5 Aarey Drugs & Pharmaceuticals Recent Developments
11.15 Aarti Drugs
11.15.1 Aarti Drugs Company Information
11.15.2 Aarti Drugs Overview
11.15.3 Aarti Drugs Metronidazole Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.15.4 Aarti Drugs Metronidazole Products and Services
11.15.5 Aarti Drugs Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Metronidazole Value Chain Analysis
12.2 Metronidazole Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Metronidazole Production Mode & Process
12.4 Metronidazole Sales and Marketing
12.4.1 Metronidazole Sales Channels
12.4.2 Metronidazole Distributors
12.5 Metronidazole Customers
13 Market Dynamics
13.1 Metronidazole Industry Trends
13.2 Metronidazole Market Drivers
13.3 Metronidazole Market Challenges
13.4 Metronidazole Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Metronidazole market size was US$ 111 million in 2025 and is forecast to reach a readjusted size of US$ 108 million by 2032 with a CAGR of -0.5% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 93
USD 4250.00
(Single User License)
The global Metronidazole market was valued at US$ 111 million in 2025 and is anticipated to reach US$ 108 million by 2032, at a CAGR of -0.5% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 123
USD 2900.00
(Single User License)
The global market for Metronidazole was estimated to be worth US$ 111 million in 2025 and is projected to reach US$ 108 million, growing at a CAGR of -0.5% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 119
USD 3950.00
(Single User License)
The global Metronidazole market is projected to grow from US$ 112 million in 2024 to US$ 108 million by 2031, at a CAGR of -0.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 168
USD 4900.00
(Single User License)
In 2024, the global market size of Metronidazole was estimated to be worth US$ 112 million and is forecast to reach approximately US$ 108 million by 2031 with a CAGR of -0.5% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 154
USD 5900.00
(Single User License)
The global Metronidazole market size was US$ 112 million in 2024 and is forecast to a readjusted size of US$ 108 million by 2031 with a CAGR of -0.5% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 99
USD 4250.00
(Single User License)
The global market for Metronidazole was estimated to be worth US$ 112 million in 2024 and is forecast to a readjusted size of US$ 108 million by 2031 with a CAGR of -0.5% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 123
USD 3950.00
(Single User License)
The global market for Metronidazole was valued at US$ 112 million in the year 2024 and is projected to reach a revised size of US$ 108 million by 2031, growing at a CAGR of -0.5% during the forecast period.
Published Date: 2025-01-16
Pages: 95
USD 2900.00
(Single User License)
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Published Date: 2024-04-16
Pages: 170
USD 5900.00
(Single User License)
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Published Date: 2024-04-07
Pages: 115
USD 4900.00
(Single User License)
The global Metronidazole market size was US$ 111 million in 2025 and is forecast to reach a readjusted size of US$ 108 million by 2032 with a CAGR of -0.5% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 93
The global Metronidazole market was valued at US$ 111 million in 2025 and is anticipated to reach US$ 108 million by 2032, at a CAGR of -0.5% from 2026 to 2032.
Published: 2026-01-04
Pages: 123
The global market for Metronidazole was estimated to be worth US$ 111 million in 2025 and is projected to reach US$ 108 million, growing at a CAGR of -0.5% from 2026 to 2032.
Published: 2026-01-04
Pages: 119
The global Metronidazole market is projected to grow from US$ 112 million in 2024 to US$ 108 million by 2031, at a CAGR of -0.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 168
In 2024, the global market size of Metronidazole was estimated to be worth US$ 112 million and is forecast to reach approximately US$ 108 million by 2031 with a CAGR of -0.5% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 154
The global Metronidazole market size was US$ 112 million in 2024 and is forecast to a readjusted size of US$ 108 million by 2031 with a CAGR of -0.5% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 99
The global market for Metronidazole was estimated to be worth US$ 112 million in 2024 and is forecast to a readjusted size of US$ 108 million by 2031 with a CAGR of -0.5% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 123
The global market for Metronidazole was valued at US$ 112 million in the year 2024 and is projected to reach a revised size of US$ 108 million by 2031, growing at a CAGR of -0.5% during the forecast period.
Published: 2025-01-16
Pages: 95
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Published: 2024-04-16
Pages: 170
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Published: 2024-04-07
Pages: 115
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now